[SGMO] YoY Quarter Result on 31-Mar-2017 [#Q1]

Stock
[SGMO] Sangamo Therapeutics, Inc.
Announcement Date
10-May-2017
Financial Year
2017
Quarter
31-Mar-2017 [#Q1]
Profit Trend
QoQ- -72.82%
YoY- -0.84%
Quarter Report
SGMO's Result
SGMO's Financial Summary
View:
Show?
Quarter Result
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
Revenue 13,076 8,071 12,637 3,425 3,942 13,491 8,116 8.26%
PBT -42,974 -42,203 -20,187 -16,632 -16,494 -6,067 -7,572 33.52%
Tax -61 -53 -588 0 -245 -748 -112 -9.62%
NP -42,913 -42,150 -20,187 -16,632 -16,494 -5,319 -7,572 33.48%
Tax Rate - - - - - - - -
Total Cost 55,989 50,221 32,824 20,057 20,436 18,810 15,688 23.59%
Ratio Analysis
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
NP Margin -328.18 -522.24 -159.75 -485.61 -418.42 -39.43 -93.30 23.29%
Per Share
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
EPS -0.37 -0.41 -0.23 -0.23 -0.23 -0.08 -0.12 20.62%
EPS Diluted -0.37 -0.41 -0.23 -0.23 -0.23 -0.08 -0.12 20.62%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.